Resonant Therapeutics is a scalable tumor microenvironment platform that speeds up therapeutic & goal discovery.
Resonant Therapeutics has raised $2.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2021.
Resonant Therapeutics's investors include Mercury.
Resonant Therapeutics is headquartered in Houston, United States.
Resonant Therapeutics is a scalable tumor microenvironment platform that speeds up therapeutic & goal discovery.
Resonant Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Resonant Therapeutics — Funding & Investors." VCBacked, October 28, 2021, https://www.vcbacked.co/company/resonant-therapeutics. Accessed August 13, 2026.
VCBacked. (2021). Resonant Therapeutics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/resonant-therapeutics
{{cite web |title=Resonant Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/resonant-therapeutics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated